Artículos del autor

solaci

Mitral valve

MitraClip: Should We Intervene Earlier?

Courtesy of Dr. Carlos Fava. Repairing the mitral valve with Mitraclip has become an alternative for high risk or inoperable symptomatic patients,...
solaci -
Institutional News

Reciprocity agreement between ESVB and SOLACI

On behalf of all who make part of SOLACI, we are thrilled to announce a reciprocity and...
solaci -
Structural heart disease

Post-dilation in TAVI associated to more stroke and more paravalvular regurgitation

Courtesy of Dr. Carlos Fava. Moderate/severe paravalvular regurgitation (PVR) after TAVR is present in 10%-14% of all cases, according to different...
solaci -
Chronic Ischemic cardiopathy

New generation DES present better results in vein grafts than older DES and BMS

There is little information comparing contemporary drug eluting stents (DES)  against bare metal stents (BMS), for PCI in...
solaci -
Chronic Ischemic cardiopathy

BVS: Controvertial Scaffold

Courtesy of Dr. Agustín Vecchia. The advent of resorbable vascular scaffolds (BVS) generated high expectations among interventionists because...
solaci -
Institutional News

CTO Summit Brazil II 2017 

An international event addressed to experts in chronic total occlusions will be held the next 15 and...
solaci -
Femoral

Critical ischemia in the lower limbs: Frequent Readmissions show the magnitude of this problem

Readmissions at 6 months in patients with critical ischemia in the lower limbs occur in about 50% of...
solaci -
Acute coronary syndromes

Prior assistance with Impella 2.5 lowers 30-day mortality in cardiogenic shock due to unprotected left main coronary artery lesion

Courtesy of Dr. Carlos Fava. The prevalence of cardiogenic shock in acute myocardial infarction (MI) is 7%-10%, and it is associated...
solaci -